PD Dr. Nadja Meindl‑Beinker is a senior researcher at Heidelberg University’s Medical Faculty Mannheim in the Molecular Hepatology department. Since 2010, her work has centered on transforming growth factor‑β (TGF‑β) signaling and its complex roles in chronic liver disease and hepatocellular carcinoma . She earned her doctorate (Dr. rer. nat.) and completed postdoctoral research at Ruhr University …
Dr. Maria Zimmermann‑Kogadeeva is a leading computational biologist and group leader in the Genome Biology Unit at EMBL in Heidelberg. After earning her PhD in 2016 from ETH Zürich’s Institute of Molecular Systems Biology, she completed postdoctoral studies at Yale—where she co-led a project revealing that gut microbes metabolize hundreds of drugs —and at EMBL, supported …
Dr. Michael Zimmermann leads the Zimmermann Group at EMBL Heidelberg, where he investigates how gut microbiota metabolize drugs, nutrients, and environmental compounds—and how this shapes host physiology. Since August 2019, he has headed this research unit, supported by a prestigious ERC Starting Grant. He received his PhD in 2015 from ETH Zurich (metabolomics and systems …
Prof. Zhan earned his MD from Heidelberg University in 2011 and began his internal medicine training at UMM that same year. From 2013 to 2018, he conducted postdoctoral research in Signaling and Functional Genomics at the German Cancer Research Center in Heidelberg. Since 2019, he has been part of the DFG-funded Clinician Scientist Program and …
Prof. Dr. Simone Schürle‑Finke, born in Ulm, Germany in 1985, is a pioneering biomedical engineer and associate professor at ETH Zürich’s Department of Health Sciences and Technology, where she leads the Responsive Biomedical Systems Laboratory SNSF Datenportal+9Wikipedia+9Wikipedia+9. After earning her diploma in industrial engineering and management at KIT with research experiences in New Zealand and Japan, …
Dr. Maria Paula Roberti is an immunologist and translational researcher based in Heidelberg, Germany. She earned her PhD in Immunology at the University of Buenos Aires, where she focused on anti-tumor innate immunity. Currently, she leads the Translational Research in Immuno‑Oncology and Microbiome (TRIM) sub‑group at the German Cancer Research Center (DKFZ) and the National Center …
Dr. Rene‑Filip Jackstadt is a clinician‑scientist and junior group leader at the German Cancer Research Center (DKFZ) and HI‑STEM in Heidelberg. He heads the “Cancer Progression and Metastasis” lab, where he leverages next‑generation colorectal cancer models—such as genetically engineered mice, patient‑derived organoids, and multi‑omics profiling—to unravel cellular programs that drive metastasis and therapy resistance, translating key …
Dr. Kim Boonekamp is a postdoctoral researcher in the Boutros Lab at the German Cancer Research Center (DKFZ) and BioQuant Heidelberg. Her work focuses on functional genomics and molecular human genetics, with a particular interest in how genetic and pharmacological perturbations shape cellular phenotypes in cancer. She works with advanced model systems such as patient-derived …
Prof. Johannes Betge is a is a physician-scientist, head of the Junior Clinical Cooperation Unit Translational Gastrointestinal Oncology and Preclinical Models at the German Cancer Research Center (DKFZ) and attending physician in gastroenterology at University Medical Center Mannheim. Prof. Betge earned his doctoral degree at Heidelberg University and completed clinical training in internal medicine at …